Indofarma Tbk Financials
| INAF Stock | IDR 126.00 0.00 0.00% |
Indofarma |
Understanding current and past Indofarma Tbk Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Indofarma Tbk's financial statements are interrelated, with each one affecting the others. For example, an increase in Indofarma Tbk's assets may result in an increase in income on the income statement.
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000068406 |
| Business Address | Jalan Indofarma No |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | indofarma.id |
| Phone | 62 21 8832 3971 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Indofarma Tbk without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Indofarma Stock, because this is throwing your money away. Analyzing the key information contained in Indofarma Tbk's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Indofarma Tbk Key Financial Ratios
Indofarma Tbk's financial ratios allow both analysts and investors to convert raw data from Indofarma Tbk's financial statements into concise, actionable information that can be used to evaluate the performance of Indofarma Tbk over time and compare it to other companies across industries.| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 | |||
| Beta | -0.22 | |||
| Z Score | 4.6 |
Indofarma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Indofarma Tbk's current stock value. Our valuation model uses many indicators to compare Indofarma Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Indofarma Tbk competition to find correlations between indicators driving Indofarma Tbk's intrinsic value. More Info.Indofarma Tbk is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indofarma Tbk's earnings, one of the primary drivers of an investment's value.Indofarma Tbk Systematic Risk
Indofarma Tbk's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Indofarma Tbk volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Indofarma Tbk correlated with the market. If Beta is less than 0 Indofarma Tbk generally moves in the opposite direction as compared to the market. If Indofarma Tbk Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Indofarma Tbk is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Indofarma Tbk is generally in the same direction as the market. If Beta > 1 Indofarma Tbk moves generally in the same direction as, but more than the movement of the benchmark.
Other Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.